Buist A S
Department of Medicine, Oregon Health Sciences University, Portland.
J Allergy Clin Immunol. 1989 Sep;84(3):275-83. doi: 10.1016/0091-6749(89)90408-9.
In this article, I have tried to present the complexity of the issues relating to asthma mortality. There are many unanswered questions and few straightforward answers. It is appropriate that we be concerned that mortality rates are apparently increasing despite the availability of better antiasthma medications and that we identify the key research studies that will allow us to answer these complex questions. At the same time, we should take this opportunity to increase our educational efforts. For the health professionals these efforts should be directed toward improving the accuracy of diagnosis and appropriateness of management in asthma. For the lay public, the efforts should be directed toward increasing the awareness of the many faces of asthma.
在本文中，我试图呈现与哮喘死亡率相关问题的复杂性。有许多未解答的问题，却几乎没有直接的答案。尽管有了更好的抗哮喘药物，死亡率仍明显上升，对此我们予以关注并确定能让我们回答这些复杂问题的关键研究，这是恰当的。同时，我们应借此机会加大教育力度。对于卫生专业人员，这些努力应旨在提高哮喘诊断的准确性和管理的恰当性。对于普通大众，这些努力应旨在提高对哮喘多面性的认识。
